Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Technology | 14.17% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3851
DELISTED
Alimera Sciences
ALIM
| $143K | ﹤0.01% |
6,853
| – | – |
2013 Q2
16 quarters
|
|
|
NWY
3852
DELISTED
New York & Co Inc
NWY
| $143K | ﹤0.01% |
104,475
+1,267
| +1% | +$1.94K |
2013 Q2
16 quarters
|
|
|
JNP
3853
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $143K | ﹤0.01% |
28,354
| – | – |
2013 Q3
15 quarters
|
|
3854
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $142K | ﹤0.01% |
2,282
| – | – |
2015 Q1
9 quarters
|
|
3855
Harte-Hanks
HHS
$32M
| $142K | ﹤0.01% |
13,796
+228
| +2% | +$2.88K |
2013 Q2
16 quarters
|
|
3856
CarParts.com
PRTS
$61M
| $142K | ﹤0.01% |
4,402
+1,417
| +47% | +$47.8K |
2013 Q2
16 quarters
|
|
3857
CVD Equipment Corp
CVV
$26.9M
| $141K | ﹤0.01% |
12,711
| – | – |
2015 Q3
7 quarters
|
|
3858
DELISTED
Dixie Group Inc
DXYN
| $141K | ﹤0.01% |
31,483
+1,198
| +4% | +$4.85K |
2013 Q2
16 quarters
|
|
|
BSQR
3859
DELISTED
BSQUARE Corporation
BSQR
| $141K | ﹤0.01% |
25,034
| – | – |
2013 Q2
16 quarters
|
|
3860
FuelCell Energy
FCEL
$1.04B
| $140K | ﹤0.01% |
314
-524
| -63% | -$232K |
2013 Q2
16 quarters
|
|
3861
DELISTED
Christopher & Banks Corporation
CBK
| $140K | ﹤0.01% |
106,505
+1,619
| +2% | +$2.06K |
2013 Q2
16 quarters
|
|
|
CIE
3862
DELISTED
Cobalt International Energy, Inc
CIE
| $140K | ﹤0.01% |
56,440
-235,917
| -81% | -$1.11M |
2013 Q2
16 quarters
|
|
3863
Tandy Leather Factory
TLF
$19.6M
| $138K | ﹤0.01% |
15,517
| – | – |
2016 Q2
4 quarters
|
|
3864
DELISTED
Cidara Therapeutics
CDTX
| $137K | ﹤0.01% |
908
-4,719
| -84% | -$652K |
2015 Q3
7 quarters
|
|
3865
Opus Genetics
IRD
$319M
| $137K | ﹤0.01% |
997
+363
| +57% | +$70.6K |
2013 Q2
16 quarters
|
|
|
ACFC
3866
DELISTED
Atlantic Coast Financial Corporation
ACFC
| $137K | ﹤0.01% |
17,437
+212
| +1% | +$1.64K |
2015 Q3
7 quarters
|
|
3867
GDS Holdings
GDS
$4.62B
| $136K | ﹤0.01% |
+14,572
| New | +$118K |
2017 Q2
0 quarters
|
|
3868
Network-1 Technologies
NTIP
$35.4M
| $133K | ﹤0.01% |
31,337
| – | – |
2017 Q1
1 quarter
|
|
3869
Tempest Therapeutics
TPST
$10.5M
| $133K | ﹤0.01% |
29
-91
| -76% | -$385K |
2013 Q2
16 quarters
|
|
3870
Civeo
CVEO
$303M
| $132K | ﹤0.01% |
5,231
-108
| -2% | -$3.22K |
2014 Q2
12 quarters
|
|
3871
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $131K | ﹤0.01% |
17,598
+5,887
| +50% | +$44.1K |
2013 Q2
16 quarters
|
|
3872
Actinium Pharmaceuticals
ATNM
$35.5M
| $130K | ﹤0.01% |
3,546
| – | – |
2014 Q2
12 quarters
|
|
|
ALR
3873
DELISTED
AlerisLife Inc
ALR
| $129K | ﹤0.01% |
8,613
| – | – |
2013 Q2
16 quarters
|
|
3874
DELISTED
Cogentix Medical, Inc.
CGNT
| $129K | ﹤0.01% |
73,926
+326
| +0.4% | +$559 |
2015 Q2
8 quarters
|
|
3875
Innovative Solutions & Support
IA
$346M
| $128K | ﹤0.01% |
29,030
| – | – |
2013 Q2
16 quarters
|
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.